Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation.
Cell death & disease 15, 858 (2024)
山中宏二先生（名古屋大学）との共同研究成果です。